Also known as a growth hormone-releasing factor and GRF 1-29, it is categorized as a growth hormone secretagogue, a compound that stimulates increased secretion of growth hormone from the pituitary gland
It would ensure a less oxidative impact of chemotherapeutic drugs on breast cancer patients, which could potentially improve their well-being
Directions for use Apply an appropriate amount to the face
It is also widely available as a dietary supplement in several forms and is frequently promoted for fat burning, performance, recovery, heart health, and cognitive support
Mechanism studied: NNMT catalyses the methylation of nicotinamide
Review papers on IV therapy warn of additional risks, including infection at the injection site, thrombophlebitis, air embolism, vein damage, electrolyte imbalances, and allergic reactions (medical review)